The impact of GLP1R rs6923761 polymorphism on metabolic changes and weight loss secondary to treatment with liraglutide was investigated in 90 overweight Spanish T2DM patients that required initiation of liraglutide treatment because they were not able to achieve good glycemic control with metformin alone. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.